Source: Okayama University (JAPAN), Public Relations and Information Strategy
For immediate release: 22 June 2016
Okayama University research: Protein for preventing heart failure
(Okayama, 22 June) A protein known to be crucial for maintaining the balance of calcium in cells could prove useful in halting the progression of heart failure.
The sodium-calcium exchanger 1 protein (NCX1) plays a major role in removing excess calcium from cells. This is particularly true in the case of the heart, where calcium levels must be carefully balanced and maintained in order to keep the organ healthy. During heart failure, scientists have noted an increase in the expression of NCX1, but its exact role during the progression of the condition remains unclear.
Now, Yuki Katanosaka and co-workers at Okayama University and Kawasaki Medical School, Japan, have shown that inducing NCX1 overexpression in the weeks following heart failure can help prevent ‘cardiac remodelling’; detrimental changes in the shape and size of the heart after it has failed.
To investigate the role of NCX1, Katanosaka’s team generated mice in which NCX1 gene expression was controlled by a cardiac-specific, doxycycline (DOX)-dependent promoter. Without DOX to trigger NCX1, the researchers found that the mice’s hearts suffered significant chamber dilation – over-stretching and thinning of the organ tissues – alongside abnormal calcium ion handling. This suggests that NCX1 may influence the structural integrity of heart cells.
In mice treated with DOX eight weeks after surgery to induce heart failure, the team found that the DOX-induced overexpression of NCX1 helped return levels of the protein to pre-surgery levels, and prevented cardiac dilation. The boost of NXC1 also returned calcium handling to normal. Katanosaka’s team found that treated heart cells also retained their integrity and their ability to contract, and did not increase in size like heart cells without NCX1 did. Other signaling processes associated with heart failure were also halted by NCX1 overexpression.
“A moderate increase of NCX1 could help prevent the development of heart failure by maintaining low Ca2+ concentration in the microdomain,” state the authors in their paper published in Cardiovascular Research (2016).
Background
Heart failure
Heart failure is a fairly common condition globally, particularly in those over the age of 65. In the UK, for example, heart failure is the reason for 5% of emergency admissions to hospital. It occurs when the heart is no longer capable of pumping enough blood around the body for a person’s needs. Symptoms include shortness of breath and extreme tiredness, and the condition can impact heavily on a sufferer’s quality of life. Heart failure is potentially fatal, and treatments focus on improvements to lifestyle that can alleviate symptoms (such as increased exercise, healthy diet, smoking cessation), as well as medication to improve heart function and blood pressure.
Investigations into the mechanisms inherent in heart failure could potentially lead to new therapies that might help repair the heart, allowing it to function as it did before heart failure set in. Similarly, it could be feasible to stop heart failure progressing, as the study by Ujihara and his team suggests.
Future work
Investigations into the fluctuations in NCX1 levels are needed to further clarify the protein’s role in heart cells over time during the course of heart failure. The insights from this study provide an excellent basis for further work into NCX1, and may one day lead to the development of new therapies to halt the progression of heart failure.
Reference
Yoshihiro Ujihara, Keiichiro Iwasaki, Satomi Takatsu, Ken Hashimoto, Keiji Naruse, Satoshi Mohri, Yuki Katanosaka. Induced NCX1 overexpression attenuates pressure overload-induced pathological cardiac remodeling. Cardiovascular Research, 26 May 2016.
DOI：10.1093/cvr/cvw113
http://www.ncbi.nlm.nih.gov/pubmed/27229460
Correspondence to
Assistant Professor Yuki Katanosaka, Ph.D.
Department of Cardiovascular Physiology, Graduate
School of Medicine, Dentistry and Pharmaceutical
Sciences, Okayama University, Shikata-cho 2-5-1,
Okayama city, Okayama 700-8558, Japan
E-mail: ytanigu(a) md.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
Contact information
Okayama University
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations and Information Strategy
E-mail: www-adm (a) adm.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
Website: //www.okayama-u.ac.jp/index_e.html
Okayama Univ. e-Bulletin: //www.okayama-u.ac.jp/user/kouhou/ebulletin/
Okayama Univ. e-Bulletin (PDF Issues): //www.okayama-u.ac.jp/user/kouhou/ebulletin/
About Okayama University (You Tube): https://www.youtube.com/watch?v=iDL1coqPRYI
Okayama University Image Movie (You Tube): https://www.youtube.com/watch?v=_WnbJVk2elA
https://www.youtube.com/watch?v=KU3hOIXS5kk
Okayama University Medical Research Updates （OU-MRU）
Vol.1：Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testingVol.2：Ensuring a cool recovery from cardiac arrestVol.3：Organ regeneration research leaps forwardVol.4：Cardiac mechanosensitive integratorVol.5：Cell injections get to the heart of congenital defectsVol.6：Fourth key molecule identified in bone developmentVol.7：Anticancer virus solution provides an alternative to surgeryVol.8：Light-responsive dye stimulates sight in genetically blind patientsVol.9：Diabetes drug helps towards immunity against cancerVol.10：Enzyme-inhibitors treat drug-resistant epilepsyVol.11：Compound-protein combination shows promise for arthritis treatmentVol.12：Molecular features of the circadian clock system in fruit fliesVol.13：Peptide directs artificial tissue growthVol.14：Simplified boron compound may treat brain tumoursVol.15：Metamaterial absorbers for infrared inspection technologiesVol.16：Epigenetics research traces how crickets restore lost limbsVol.17：Cell research shows pathway for suppressing hepatitis B virusVol.18：Therapeutic protein targets liver diseaseVol.19：Study links signalling protein to osteoarthritisVol.20：Lack of enzyme promotes fatty liver disease in thin patientsVol.21：Combined gene transduction and light therapy targets gastric cancerVol.22：Medical supportive device for hemodialysis catheter punctureVol.23：Development of low cost oral inactivated vaccines for dysenteryVol.24：Sticky molecules to tackle obesity and diabetesVol.25：Self-administered aroma foot massage may reduce symptoms of anxiety